Table 1

Primary antibodies used for the study.

Antibody

Clone

Source

Antigen retrieval

Dilution


CD3

SP7

Immunotech

EDTA 750 W

1:250


CD5

54/F6

Dako

EDTA 900 W

1:10


CD10

56C6

Novocastra

EDTA 900 W

1:5


CD20

L26

Dako

EDTA 750 W

1:200


CD23

1B12

Novocastra

EDTA 900 W

1:30


CD30

Ber- H2

Prof. Falini *

EDTA 900 W

1:3


CD38

SPC32

Novocastra

EDTA 750 W

1:10


CD79a

JCB117

Prof. Mason §

EDTA 750 W

1:10


CD138

-

Neomarkers

EDTA 900 W

1:20


BCL-1

SP4

Neomarkers

EDTA 900 W

1:20


BCL-6

PG-B6p

Prof. Falini *

EDTA 900 W

Undiluted


BCL-2

124

Prof. Mason §

EDTA 900 W

1:3


IRTA-1

Mum2EC

Prof. Falini *

EDTA 900 W

1:2


MUM1/IRF4

-

Prof. Falini *

EDTA 900 W

1:2


TdT

-

Dako

None

1:30


ALKc

-

Prof. Falini *

EDTA 900 W

1:2


Ki-67

Mib-1

Dako

EDTA 900 W

1:20


* Kindly provided by Prof. Brunangelo Falini, Perugia University, Perugia, Italy.

§Kindly provided by Prof. David Y. Mason, Oxford University, Oxford, before his premature death.

Tumwine et al. BMC Clinical Pathology 2009 9:11   doi:10.1186/1472-6890-9-11

Open Data